The National Human Rights Commission (NHRC) has asked the union health and family welfare ministry to set up a committee to monitor the misuse of banned Diclofenac, an anti-inflammatory drug, in animal in India.
Acting on a complaint by Odisha-based human rights activist Akhand, the NHRC also asked the ministry to direct all state governments to take steps for strict implementation of the directions of the Centre in this regard.
Taking up the issue of May 2014, the NHRC has directed the health and family welfare secretary to submit the ministry's response over the misuse of Dicolfenac - a banned livestock pain killer and a killer of vultures in the country.
The rights activist has alleged that though Diclofenac was banned for animal use, it was readily available with the chemists and private drug stores because it can be used to treat humans too.
The normal dose of the drug in animals is about 11 ml for three or four days while the human dose is only 3 ml per dose, said the petitioner.
Mass killing of vultures creates environmental imbalance that affects human life.
As carcasses once eaten by vultures now rot in village fields, drinking water has become seriously contaminated and endangers human life. It was a major human rights violation, said Akhand.
The central government has already banned the formulation, manufacture and import of veterinary Diclofenac in 2008.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
